Download PDF
1 / Pages

Other users also viewed these articles

Considerations for optimizing Wilson¿s disease patients¿ long-term follow-up Gilberto Herrera-Quiñones; Angella María Dafieno; Yaroslau Compta; Xavier Forns; Zoe Mariño;
Gastroenterol Hepatol. 2022;45:146-54
Changes in indications for outpatient percutaneous liver biopsy over 5 years: from hepatitis C to fatty liver disease Marlone Cunha-Silva; Luíza D. Torres; Mariana F. Fernandes; Tirzah de M. Lopes Secundo; Marina C.G. Moreira; Ademar Yamanaka; Leonardo T. Monici; Larissa B. Eloy da Costa; Daniel F. Mazo; Tiago Sevá-Pereira;
Gastroenterol Hepatol. 2022;45:579-84
Concordance between hepatic biopsy and the APRI index (Ast to Platelet Ratio Index) for the diagnosis of cirrhosis in patients with autoimmune liver disease Carmen Yanette Suarez-Quintero; Oscar Patarroyo Henao; Oscar Muñoz-Velandia;
Gastroenterol Hepatol. 2021;44:465-71